14 May 2009 /News - miscellaneous
A number of medicines are available on the market for the treatment of life-threatening obesity. Most of these products are sold on prescription, but just recently a new medicine called Alli® was launched for over-the-counter sale.
13 May 2009 /Side effects and trials
In a new study in rats, scientists from the Italian Instituto di Neuroscienze in Pisa have discovered that Botulinumtoxin A injected into the jaw muscle of rats had found its way to the rats' brains three day after and that it was still present in the rats' brains after six months.
11 May 2009 /Product information
The European Medicines Agency, EMEA, has reassessed the use of Tamiflu® in pregnant women and infants who are ill with influenza A(H1N1).
07 May 2009 /Product information
Stop using Hydroxycut pills, powder and capsules and talk to your doctor about possible side effects or symptoms of liver damage (jaundice, darkening of urine, nausea, vomiting, light-coloured stools, excessive fatigue, stomach or abdominal pain, itching and loss of appetite).
06 May 2009 /Side effects and trials
Voluntary Harmonisation Procedure (VHP) for the assessment of multinational clinical trial applications
The Voluntary Harmonisation Procedure is a procedure which makes it possible to obtain a coordinated assessment of an application for a clinical trial that is to take place in several European countries.
04 May 2009 /Prices and reimbursement
Consultation on the reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)
At the Danish Medicines Agency's request, the Reimbursement Committee has reassessed the reimbursement status of medicinal products authorised for marketing in Denmark in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)
04 May 2009 /News - miscellaneous
The computer security company McAfee has reported floods of spam e-mails that attempt to exploit people who worry about the swine flu.
04 May 2009 /Product information
From today, pharmacies across Denmark will be offering the weight-loss product Alli®. Alli® contains the active ingredient orlistat, which has been authorised in Denmark and other EU countries since 1998 as a prescription-only weight-loss product.
01 May 2009 /Retail and online sale
It is easy to find and buy potency-enhancing pills on the internet. Unfortunately, many of them are not approved by the authorities. This means that they may be detrimental to your health.